Skip to main content
Smart Investors Daily
EX

NYSE · EXPO

Exponent, Inc.

Industrials · Consulting Services

$80.26

Up+$1.95 (+2.49%)

Updated Nov 1, 2026, 7:25 AM

SID Score

6.9/10

Composite research score

Smart Money

58/100

Neutral

Market cap
3.67B
P/E ratio
35.82
Dividend yield
1.50%
52-week range
$51.91 – $83.18
Volume
773.55K
Avg. volume
408.27K

Price performance · EXPO

EXPO price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

EXPO closed at $80.26 after 20 trading sessions, up 16.74% for the selected period.

Last close
$80.26
Period change
+16.74%
Period low
$68.75
Period high
$80.26
Daily close
View OHLC price history
EXPO OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$81.06$83.18$80.03$80.26773.55K
Oct 29, 2026$78.10$79.06$77.02$78.31879.33K
Oct 28, 2026$75.82$77.3452$75.63$77.11581.41K
Oct 27, 2026$77.61$77.61$75.775$76.45268.76K
Oct 26, 2026$77.46$78.43$76.945$77.66710.86K
Oct 23, 2026$76.56$77.69$75.70$77.43377.8K
Oct 22, 2026$73.90$77.13$73.78$77.11785.04K
Oct 21, 2026$72.15$73.39$72.02$73.15599.16K
Oct 20, 2026$73.00$73.825$72.15$72.55787.42K
Oct 19, 2026$71.51$72.90$71.12$72.25603.95K
Oct 16, 2026$72.81$73.46$71.56$71.85354.96K
Oct 15, 2026$72.11$73.235$71.5441$72.28459.43K
Oct 14, 2026$70.76$71.49$70.465$71.10486.7K
Oct 13, 2026$71.28$71.8286$70.05$71.26315.05K
Oct 12, 2026$69.81$70.94$69.4518$70.67516.87K
Oct 9, 2026$70.00$70.35$69.42$69.81373.01K
Oct 8, 2026$68.72$70.10$68.26$69.78889.89K
Oct 7, 2026$68.91$69.90$68.305$68.95765.32K
Oct 6, 2026$69.13$69.45$68.525$69.18427.99K
Oct 5, 2026$66.92$69.04$66.92$68.75645K

Latest EXPO news

The latest Smart Investors Daily articles mentioning EXPO.

EXPO research

Overview

Company profile and research snapshot.

Company profile

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$104.00
Implied upside
—
Analysts
9
EXPO recent ratings
DateFirmRatingTarget
Jul 31, 2026JP MorganOverweight—
Jul 31, 2026UBSNeutral—
May 15, 2026JP MorganOverweight—
May 1, 2026UBSNeutral—
Mar 26, 2026JP MorganOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 18, 2026

3 Quality Stocks With ROE Over 30%

Interest payments on US government debt now cost about US$3b a day, which concentrates attention on balance sheet strength wherever you invest. When public finances look stretched, investors often care more about companies that generate solid returns on shareholder capital and keep their own debt under control. This article highlights three stocks that combine high return on equity, resilient historic execution and clean finances from our strong balance sheet screen. The three examples in...

Yahoo · Oct 10, 2026

Exponent (EXPO) Stock Looks Reasonable Against Its Cash Flow Value

Exponent has had a mixed share price journey in recent years, and that uneven path puts the spotlight squarely on whether the current US$69.81 price is supported by the cash the business can generate. With a Discounted Cash Flow (DCF) intrinsic value estimate available, the question is how closely that market tag lines up with the cash flow outlook investors are effectively paying for today. Over the past 5 years the stock has declined 32.9%, which makes the gap between long term share...

Yahoo · Oct 8, 2026

Exponent to Announce Third Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on October 29, 2026

MENLO PARK, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report third quarter of fiscal year 2026 financial results for the period ended October 2, 2026 following the close of the market on Thursday, October 29, 2026. On that day, Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson, will host a conference call and webcast at 4:30 p.m. ET (

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.